Skip to main content
Equibles

Velan Capital Investment Management LP

Position in LYEL — Lyell Immunopharma, Inc.

CIK 1848809 ALPHARETTA, GA
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,475,250
-$570,870 QoQ
Shares Held
105,000
+2.9% QoQ
Ownership
0.428%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#21
of 87 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Velan Capital Investment Management LP holds $153,684,284 across 45 Biotechnology names. LYEL ranks #19 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRAX
Praxis Precision Medicines, Inc.
 88,781 $29,722,990
2 MPLT
MapLight Therapeutics, Inc.
 492,893 $17,665,285
3 STRO
Sutro Biopharma, Inc.
 512,160 $17,003,712
4 IMMX
Immix Biopharma, Inc.
 1,085,000 $11,186,350
5 TARA
Protara Therapeutics, Inc.
 2,844,652 $10,866,570
6 ABVX
Abivax S.A.
 65,630 $8,745,853
7 TENX
Tenax Therapeutics, Inc.
 549,985 $8,002,281
8 EDSA
Edesa Biotech, Inc.
 827,500 $6,727,575

All Filings in LYEL

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,475,250 105,000
2026-03-31 $2,046,120 102,000